Education
About Us
Working with TipRanks
Follow Us
Michael J Rossi Insider Profile
4 Followers
Michael J Rossi, Medical Group President at Mirion Technologies, holds 137.08K shares in Y-Mabs Therapeutics (Ticker: YMAB), holds 116.17K shares in Mirion Technologies (Ticker: MIR). Most recently, Michael J Rossi Sold ― shares of Y-Mabs Therapeutics on Mar 11, 2025 for an estimated value of 20.37K.
Michael J Rossi has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Michael J Rossi holds in companies
Most Profitable Insider Trade
The most profitable trade made by Michael J Rossi
Michael J Rossi's Trading History
Mirion Technologies
Nov 03, 2023
Medical Group President
Uninformative Sell
38.21K
$2.55M
Y-Mabs Therapeutics
Mar 11, 2025
PRESIDENT & CEO, Director
Informative Sell
20.37K
$653.89K
List of latest transactions for each holding click on a transaction to see Michael J Rossi's performance on stock
You May Also Like
Michael J Rossi insider profile FAQ
What is the percentage of profitable transactions made by Michael J Rossi?
The percentage of profitable transactions made by Michael J Rossi is ―.
What is the average return per transaction made by Michael J Rossi?
The average return per transaction made by Michael J Rossi is ―.
What stocks does Michael J Rossi hold?
Michael J Rossi holds: MIR, YMAB stocks.
What was Michael J Rossi’s latest transaction?
Michael J Rossi latest transaction was an Informative Sell of $20.37K.
What was Michael J Rossi's most profitable transaction?
Michael J Rossi’s most profitable transaction was an Informative Sell of YMAB stock on March 11, 2025. The return on the trade was 12.70%.
What is Michael J Rossi's role in Mirion Technologies?
Michael J Rossi's role in Mirion Technologies is Medical Group President.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.